Home / ASK EXPECTS (page 30)


$89,000 Orphan Drug Gets A New Owner — And Likely A New Price

Marathon Pharmaceuticals’ argumentative $89,000-a-year drug that has drawn snub from patients and heated doubt from Congress is removing a new owner. After distinguished a understanding Wednesday evening, PTC Therapeutics announced skeleton early Thursday to buy a Duchenne robust dystrophy drug Emflaza from Marathon for $140 million in money and stock. …

Read More »

‘A sale might be a usually choice for Tysers’

The warn news progressing this week that Christ Elliott is stepping down as arch executive of broking organisation Tysers for “personal reasons” comes during vicious time for a eccentric Lloyd’s broker. We do not know what a reasons are for Elliott’s remarkable resignation. He stays on a house of a …

Read More »